Momenta Pharma
(MNTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Sales | 12,728 | 5,102 | 21,863 | 24,228 | 29,455 |
| Gross Profit | 12,728 | 5,102 | 21,863 | 24,228 | 29,455 |
| Operating Expenses | 30,914 | 31,232 | 32,364 | 29,517 | 30,954 |
| Operating Income | -18,186 | -26,130 | -10,501 | -5,289 | -1,499 |
| Interest Expense | 0 | 0 | 0 | 0 | 2 |
| Other Income | 508 | 308 | 335 | 307 | 248 |
| Pre-tax Income | -17,678 | -25,822 | -10,166 | -4,982 | -1,253 |
| Net Income Continuous | -17,678 | -25,822 | -10,166 | -4,982 | -1,253 |
| Net Income | $-17,678 | $-25,822 | $-10,166 | $-4,982 | $-1,253 |
| EPS Basic Total Ops | -0.35 | -0.51 | -0.20 | -0.10 | -0.03 |
| EPS Basic Continuous Ops | -0.35 | -0.51 | -0.20 | -0.10 | -0.03 |
| EPS Diluted Total Ops | -0.35 | -0.51 | -0.20 | -0.10 | -0.02 |
| EPS Diluted Continuous Ops | -0.35 | -0.51 | -0.20 | -0.10 | -0.03 |
| EBITDA(a) | $-14,982 | $-23,146 | $-7,974 | $-3,236 | $230 |